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Background 
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) high infectivity and 
perceived substantial fatality rates are causing negative psychosocial effects, including 
the increased psychiatric and economic burden. Research has demonstrated that a severe 
diagnosis triggers various responses in a person, including depression, sense of 
hopelessness, shame, and self-destructive behaviours. This manuscript explores the 
reasons why people did not follow the recommendations to be tested for SARS-CoV-2. 
Methods 
A mixed study design, sequential explanatory study was carried out from March-Dec 
2020, based on an online COVID-19 symptom checker. Quantitative and qualitative data 
were collected. Video interviews were held with Key Informants (n=19), who were selected 
purposefully from the online tool users’ group that consented to the study. 
Results 
Among 176 users of the online triage tool, 150 (85%) followed the recommendations and 
26 (15%) did not. The reasons people did not test for SARS-CoV-2 emerged as fivefold: i) 
improved symptoms, ii) the cost of test, iii) fear of a painful test procedure, iv) test kit 
shortages, and v) fear of a positive SARS-CoV-2 test result. 
Conclusions 
Of the reasons why people did not test, fear of a positive SARS-CoV-2 result remains 
unaddressed in our view. Integrating pre- and post-test counselling into SARS-CoV-2 
testing strategies, similarly as done for HIV-testing, seems warranted to address this 
problem. 
Dealing with a life-threatening illness exhibits different 
reactions in people. This is of special interest in the situa-
tion where the whole world is faced with an unprecedented 
challenge of severe acute respiratory syndrome coronavirus 
2 (SARS-CoV-2). Its high infectivity and perceived substan-
tial fatality rates may cause psychosocial effects including 
psychiatric and economic burdens.1–3 Research has demon-
strated that a severe and potentially fatal diagnosis triggers 
various responses in a person, including depression, denial, 
hopelessness, shame, self-destructive behaviours, and in-
somnia,4 most of which have also been associated with 
COVID-19. This is further exemplified by the daily reports 
on the number of infected, those at the intensive care units 
and deceased.5–7 Some studies have revealed that the cu-
mulative approach to tracking COVID-19 increases fear and 
anxiety among the public.5 The fear COVID-19 engenders in 
people ought to be acknowledged for the battle to be won.8 
Corona phobia, meaning mass fear of the virus, has been 
associated with psycho-social illnesses after the infection.1 
Three common strategies to combat the spread of SARS-
CoV-2 are lockdowns, quarantine and isolation. The diag-
nosis of COVID-19 accompanied with the required isola-
tion, has been revealed to cause acute panic, anxiety, 
depression, stigmatization, and even elements of racism 
in some instances.1 Front line health care workers have 
not been spared either, with some suffering from burn out, 
fear of transmitting infection to family members, fear of 
contracting infection and even developing a post-traumatic 
stress disorder.1,2 Finally, the breadth of media coverage, 
the “infodemic”, further contributed to this situation and 
aggravated psychosomatic conditions like depression and 
anxiety, amongst all socio-economic strata, possibly to a 
greater extent than the virus itself,1 making this epidemic a 
real public health issue. 
Social stigma, blame and loneliness associated with 
COVID-19 have also been reported. Social stigma has been 
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associated with avoidance of testing.9 It has been defined 
as an attribute which is deeply discrediting, reducing a per-
son in the widest sense of that word.9,10 It is most closely 
felt in the index cases, and its detrimental effects are visible 
not only in fear, but also in blame.10 One of the most dev-
astating effects of stigmatization on the societal level is the 
avoidance of testing, rising from the shame and even self-
rejection, a special form of internalized stigma.10 
The aim of this study was to explore and understand if 
OFTT users followed the recommendations given and the 
reasons they followed or disregarded these. In addition, we 
explored the psychosocial consequences of a COVID-19 di-
agnosis that might be preventing people from testing, and 
impacting their mental health, too. 
METHODS 
CONTEXT AND INTERVENTION 
The Department of emergency medicine at Inselspital, Bern 
University Hospital, developed an online forward triage tool 
(OFTT).This OFTT was, to the best of our knowledge, one of 
the first of its kind in Switzerland.11 Recommendations to 
test or not to test were made in accordance with frequently 
changing guidelines about testing published by the federal 
office of public health (FOPH). The aim of the OFTT was to 
provide the users with recommendations about testing in 
Switzerland during the first COVID-19 wave. 
We carried out the mixed study design to explore the ef-
fects and utility of the OFTT. The rationale for collecting 
both quantitative and qualitative data in one study is that 
neither method is sufficient by itself; only a combination 
of both approaches can yield a holistic picture of a phe-
nomenon. Quantitative and qualitative methods comple-
ment each other and may yield advantages that are not 
accessible in a single-approach study. This manuscript ex-
plores why people did not follow the recommendations to 
test for COVID-19, while the utility and effects of an online 
COVID-19 symptom checker were published separately.12 
DATA COLLECTION AND ANALYSIS 
The survey instrument was pilot tested, by inviting the 
emergency room physicians to fill it out. After achieving 
satisfactory results of the piloting, we offered the survey to 
the target sample. The data collection began on March 2, 
2020 and ended on Dec 10, 2020. Quantitative data was col-
lected from all OFTT users between March 2 and May 12, 
2020. The database complied with the Swiss laws of col-
lecting personal health related data. Participants that con-
sented to a follow-up study were invited to take part in an 
online survey to ascertain if they indeed followed the online 
tool recommendations and why they had done or not done 
so. 
QUANTITATIVE DATA AND SAMPLING 
Quantitative data was analysed in Stata® 16.1 (StataCorp, 
The College Station, Texas, USA). Descriptive statistics for 
all variables were computed as mean, standard deviation, 
and range or frequency as determined by the type of the 
data. 
QUALITATIVE DATA 
Qualitative data was collected between 17 August 2020 and 
10 Dec 2020. Qualitative data was collected in order to sup-
plement the quantitative findings, as well as understand the 
reasons why participants followed or disregarded recom-
mendations. The sample was derived from OFTT users who 
had taken part in the online survey, and had additionally 
consented to follow-up qualitative interviews, in a multi-
stage sampling scheme. In order to ensure that participants 
from all age groups were included, purposeful and quota 
sampling were performed. Video interviews were held with 
Key Informants (n=19). The interviews were audio recorded 
and transcribed verbatim. 
CENTRAL QUESTION 
“Why did people that got a recommendation to test for 
COVID-19 not do so?” 
QUALITATIVE DATA ANALYSIS 
An iterative, deductive and inductive approach was utilized 
to analyse data. Transcribed data were coded thematically 
with the aid of MAXQDA2018 (VERBI software, Berlin). 
Measures to ensure trustworthiness of data were taken. For 
dependability, the data collection process is well described 
and two experienced qualitative researchers kept reflexive 
journals through-out data collection and analysis phases. 
Debriefings after end of interviews were conducted daily 
and two researchers experienced in qualitative methods 
coded the data independently for themes before reaching 
consensus. To ensure confirmability, we discussed findings 
with experts in the field of HIV, infectious diseases and 
telemedicine, and incorporated their responses. Partici-
pants, context and process of analysis have been described 
in detail to enhance transferability. Interviews were only 
stopped after reaching data saturation. After the 9th key in-
formant interview, themes started to be repetitive with no 
new themes emerging. 
KEY INFORMANTS AND SAMPLE SIZE 
The sample was derived from OFTT users that had taken 
part in the online survey and had further consented to fol-
low-up qualitative interviews-multistage sampling. In or-
der to ensure that participants from all age groups were in-
cluded, purposeful and quota sampling were done (Table 
1). 
ETHICS APPROVAL 
The local ethics committee of Canton Bern, Switzerland, 
deemed this project a quality evaluation study, and waived 




There were 6,272 users of the OFTT between March 2 and 
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Table 1. Key informant demographics 
Age groups 18-29 30-45 46-64 65+ Total 
Males 1 2 3 4 10 
Females 2 2 4 1 9 
Total 3 4 7 5 19 
Table 2. Summary of themes in qualitative analysis 
Theme Category Unit meaning 
1. People did not test when the symptoms improved Natural recovery process 
2. People did not test due to the cost of test Economic factor 
3. People did not test due to fear of a painful test 
procedure (rumours) 
Information, education, and 
communication (IEC) 
4. People did not test because of test kit shortages Supply chain challenges 
Pandemic preparedness 
5. People did not test due to fear of a positive test 
result 
Psychological readiness to accept 
diagnosis 
• improved symptoms 
• cost of COVID-19 test deterred 
some 
• misinformation-rumours that 
test is very painful 
• test kit shortages-testing ca-
pacity 
• fear of a positive test and its 
consequences 
• prefer not to know 
May 12, 2020; 176 of them consented to participate in a 
follow-up study. The participants’ mean age was 50.1 years 
(SD 15.4, range 18-82). There were 101 (57.4%) women 
among them, with 31 (17.6%) of the elderly, aged 65 and 
above. The vast majority followed the given recommenda-
tions given, 150 subjects (85%) and 26 subjects (15%) did 
not. 
QUALITATIVE FINDINGS 
Most of the participants revealed that test kit shortages ex-
perienced during the early phases of the pandemic, the cost 
of the test at the time, improved symptoms, and fear of a 
painful test (disinformation) were some of the reasons peo-
ple did not test (Table 2). 
Most of the participants also expressed fear and when 
probed revealed the following: 
With all the consequences, one thinks it’s better not to 
test, I would rather not know and continue working – Key 
informant 8 
Fear of a positive result is the reason. Many people are 
afraid of a positive COVID 19 test. That is what I heard 
from my friends and colleagues. Many said they would 
rather stay at home, isolate and that’s it, rather than deal 
with a positive test – Key informant 18 
DISCUSSION 
This study identified a framework of five reasons of failure 
to follow recommendations to be tested for COVID-19. 
These reasons included: i) the lack of testing when the 
symptoms improved, ii) problems due to the cost of testing 
iii) fear of a painful testing procedure, iv) kit shortages, and 
v) fear of a positive test result. The most salient result of 
this study is the emergence of fear and psychological readi-
ness to receive such a diagnosis. 
The majority of the reasons revealed are addressed easily 
and have been solved in most countries. Lack of testing in 
the face of improved symptoms is a natural disease course 
pattern, and therefore presents an understandable situation 
where no further diagnostic procedure may seem war-
ranted. Shortage of test kits and fear of a painful testing 
are all barriers that can be addressed through a functional 
supply chain, information, education and open communi-
cation. Financial challenges associated with the cost of test-
ing have already been addressed by making the SARS-CoV-2 
test free in many countries, including Switzerland. 
Contrary to this, the fear of a positive SARS-CoV-2 result 
remains largely unaddressed. Several previous studies have 
reported prevalent psychiatric conditions following 
COVID-19.8,13,14 Any new and potentially life-threatening 
disease in a population seems to be associated with psycho-
social and behavioural issues that need to be taken into 
account.4 The fear of a positive test result and resultant 
consequences have also been previously reported.13,14 The 
psychological readiness of patients, to deal with a diagnosis 
that is new and considered severe seems to fuelling this. We 
feel this is important particularly as rapid tests are being 
rolled out.13 
ISOLATION AND SOCIAL DISTANCING 
Strategies currently in use to curb the spread of the virus are 
isolation, immediately post diagnosis and quarantine after 
exposure, and these seem to exacerbate fear in some, lead-
ing to mental health challenges in the long run. Our re-
search revealed that dealing with fear and the psychologi-
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Figure 1. The framework of the reasons for non-testing and possible measures to tackle them 
cal readiness of patients to receive a COVID-19 diagnosis, 
are important but seemingly neglected issues.14 If almost 
1 in 5 people diagnosed with COVID-19 are diagnosed with 
a mental illness within 3 months of their positive test,15 
with prevalent neuro-psychiatric sequelae,16 then our per-
ception and the importance of this infection must be re-
considered. This is further aggravated by the negative con-
sequences of loneliness and isolation, in addition to the 
disease itself,17,18 suggesting that this is a real public health 
priority at a population level. Psychosocial crisis prevention 
and interventions should therefore be urgently developed 
and expanded as a public health measure.1 Telemedicine 
interventions could be employed to address both the pan-
demic and infodemic needs.1,14 The need for psychosocial 
preparedness in future pandemics cannot be over empha-
sized.1 
ARE WE SEEING THIS FOR THE FIRST TIME? 
No; a diagnosis with a life-threatening illness is known to 
be associated with psychosocial behaviours.4 This was espe-
cially true for cancer; preparing the patients for a possible 
cancer diagnosis, providing information, life expectancy, 
effect of cancer on other life aspects and involvement of 
close relatives, were associated with lower incidents of de-
pression and positive patient outcomes.19 
LEARNING FROM HIV TESTING 
In the early 80s, HIV was a fatal disease that was associated 
with substantial stigma and blame, providing the grounds 
for a direct comparison with COVID-19. How did we cope 
back then? Pre and post-test counselling were introduced 
after realizing that many patients did not manage to cope 
well with HIV diagnosis.20 The existing evidence shows that 
subjects who experienced pre- and post-counselling were 
able to cope with their illness better, and were more likely 
to look after their health and protect others from infec-
tion.14,20–22 In support of our findings, parallels between 
HIV and COVID-19 have also been mentioned elsewhere.23 
It could easily be that this kind of COVID-19 diagnosis im-
pact is currently underestimated. 
PRE- AND POST-TEST COUNSELLING AS A PUBLIC 
HEALTH TOOL TO FIGHT COVID-19 RELATED FEAR 
Pre and post counselling could be done by a nurse or GP 
with the help of digital tools. Telemedicine, in the form of 
phone or video consultations, have already proven effective 
during this pandemic.24 We therefore propose to offer pre 
and post-test counselling - a cheap, affordable, accessible, 
and sustainable public health tool, as an additional strategy 
to address COVID-19 related fear to the patients. Additional 
lessons could also be drawn from HIV second generation 
surveillance, through strategic concentration of informa-
tion and resources, that help build up an informative pic-
ture of changes in the COVID-19 pandemic overtime.25 
STRENGTHS AND LIMITATIONS 
Our OFTT was one of the first COVID-19 OFTT to be set 
up in Switzerland. The insights gained here could be used 
to inform and improve future COVID-19 and other pan-
demic tools. While many OFTTs are collecting quantitative 
data only, we employed a mixed study design, yielding a 
holistic picture, going beyond reporting the proportion of 
OFTT users that does not follow recommendations to test. 
This information is invaluable in improving the utility of 
COVID-19 and other OFTTs as well as patient outcomes. 
Online tool users do not necessarily have to be focused 
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on those with a disease. Worried people usually search for 
symptoms online to ascertain whether or not to seek med-
ical care. At the same time, others might have used the tool 
for test runs, simply to acquaint themselves with the tool it-
self or COVID-19 expected signs and symptoms, as this in-
formation was unknown and scarce at the beginning of the 
pandemic. One limit of our study could be the low partici-
pation rate in the follow-up study. That could mean that the 
population that consented to study might not be represen-
tative of all online OFTT users. In order to make our OFTT 
available to as many people as possible, to minimize barri-
ers to use and to comply with data protection regulations, 
we have nevertheless refrained from a mandatory follow-up 
survey. 
The analogy of COVID and HIV has some inherent lim-
itations. For example, unlike COVID, the stigma associated 
with HIV is not only rooted in the direct and indirect effects 
of the disease itself, but also in the primarily sexual mode 
of transmission. Secondly, HIV diagnosis implies living with 
the virus lifelong and taking lifelong treatment with effects 
on quality of life. While data on long-COVID is still emerg-
ing, the majority of the COVID-19 cases on the other hand, 
are usually milder, with the virus expected to clear within 
three months at most. Nevertheless, we believe that this 
analogy can help highlight similar psychosocial impacts be-
tween HIV and COVID-19 which might lead us to applicable 
solutions and learned lessons from the past. 
CONCLUSIONS 
A novel, perceived life-threatening disease in a population 
is associated with psycho-social and behavioural issues that 
need to be taken into account. Fear of a positive SARS-
CoV-2 testing result remains largely unaddressed. This is 
clearly seen in the previous comment: “Respect the fear indi-
viduals have about COVID-19. Acknowledge it. Listen to what 
they have to say. Support them. Be patient and compassionate. 
And we can overcome the fear and defeat COVID-19 together.” 
(December 2020).8 Integrating pre- and post-test coun-
selling into SARS-CoV-2 testing strategies, as was done for 
HIV-testing, may be a useful tool to address COVID-19 re-
lated fear. 
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